Aging
Navigate
Submit an Article
Research Paper|Volume 8, Issue 12|pp. 3520–3534
Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer
Back to articleFigure 3A(3 of 11)
100%
Figure 3A
Figure 3A.The combination therapy enhanced the proliferation inhibition of HUVECs cells in vitro.